Pharmaceutical Communiqué: Q3 – 2009

Leaders in Life Science Learning Program Deemed a Success

Last week, we launched a new program called Leaders in Life Science Learning (LLL), a six-city road trip focused on best practices in compliance and quality training for pharma, biotech and device companies.  The goal of the program is to create a community of professionals that will share their best-in-class practices on implementing optimal quality and compliance programs with industry peers.   The program begins and ends in New Jersey and stops in Boston, Chicago, Seattle and Northern California. 

The LLL arose out of our annual Knowledge Summit program.  Our clients and prospects were clamoring for a forum to discuss ongoing best practices in quality, compliance and training and continue to learn from one another.  The community will convene formally and informally to expand the knowledge base and develop new solutions. 

>>Read the full article by registering for access to this content

 

We invite you to download an article written by Ellen Leinfuss, Kaplan EduNeering's Chief Marketing Officer, which appeared in the July issue of BioPharm International.

In his testimony regarding the heparin tragedy, before the Subcommittee on Oversight and Investigations - Committee on Energy and Commerce, Robert L. Parkinson, CEO of Baxter International said, "The complexity of the global drug supply chain creates new and emerging risks that call for new ways of thinking about, identifying and addressing vulnerabilities. Resting on old standards - even ones that have worked for decades - is no longer enough."

Ensuring product quality should not rely only on certifications by suppliers or inspections by the FDA. This article encourages pharmaceutical companies to follow a three-prong approach to managing quality across their supply chains: validate, verify, and implement.

>>Read the full article by registering for access to this content

Back to: Newsletters

  

Download Now